KOREASCHOLAR

The Extract of Kochia scoparia Fruit Induces Programmed Necrosis in Oral Squamous Cell Carcinoma Cells Kochia scoparia 열매 추출물이 구강 편평세포암종세포에서 예정된 괴사 유도

Hye-Yeon Han, Bong-Soo Bark, Hyung Joon Kim, Seung-Hwa Jeong, Jiyeon Kim, Sung-Hee Jeong, Gyoo Cheon Kim, Dae-Seok Hwang, Uk-Kyu Kim, Hyungwoo Kim, Mi Heon Ryu
  • 언어ENG
  • URLhttp://db.koreascholar.com/Article/Detail/322496
대한구강악안면병리학회지
제40권 제6호 (2016.12)
pp.899-909
대한구강악안면병리학회 (Korean Academy Of Oral And Maxillofacial Pathology)
초록

The fruit of Kochia scoparia Scharder is traditionally used as a medicinal ingredient to treat allergic skin diseases and inflammatory diseases in China, Japan and Korea. Recently, several studies reported that K. scoparia had potential for the cytotoxicity of human cancer cells. To investigate the anti-cancer effect of K. scoparia on oral cancer and to determine the specific type of cell death induced by MEKS treatment. We investigated the anti-cancer effects of K. scoparia, methanol extract (MEKS) in HSC4 human oral cancer cells. We examined the effects of MEKS on the proliferation rate, cell cycle arrest, 7-AAD-ANNEXIN V double stain, reactive oxygen species (ROS) generation and activation of apoptosis and necroptosis-associated proteins in HSC4 cells. MTT assay results demonstrated that MEKS decreased the proliferation rates of HSC4 cells in a dose-dependent manner with an IC50 value of 45.3 μg/ml. MEKS at 50 μg/ml significantly increased the sub-G1 DNA contents of HSC4 cells to 84.8%, versus untreated cells. However, the activation of apoptosis-associated proteins such as cleaved caspase 3, cleaved caspase 8, cleaved caspase 9 and cleaved Poly (ADP-ribose) polymerase (PARP) did not detect. The level of Bax protein markedly increased in MEKS-treated HSC4 cells. In addition, the cell viability of the DPQ pre-treated HSC4 cells with MEKS treatment was significantly greater than that of MEKS treated-cells. These results suggest that MEKS inhibits cell proliferation and induces necroptosis in oral cancer cells and that MEKS may have potential chemotherapeutic value for the treatment of human oral cancer.

저자
  • Hye-Yeon Han(Department of Oral Pathology, School of Dentistry, Research Institute for Oral Biotechnology) | 한혜련 Correspondence
  • Bong-Soo Bark(Department of Dental Anatomy, BK21 Plus project, School of Dentistry) | 박봉수 Correspondence
  • Hyung Joon Kim(Department of Oral Physiology, BK21 Plus project, School of Dentistry) | 김준형
  • Seung-Hwa Jeong(Department of Preventive and Community Dentistry, BK21 Plus project, School of Dentistry,) | 정승화
  • Jiyeon Kim(Department of Pediatric Dentistry, School of Dentistry, Dental Research Institute) | 김지연
  • Sung-Hee Jeong(Department of Oral Medicine, School of Dentistry, Dental Research Institute) | 정성희
  • Gyoo Cheon Kim(Department of Dental Anatomy, BK21 Plus project, School of Dentistry) | 김규천
  • Dae-Seok Hwang(Department of Oral and Maxillofacial Surgery, School of Dentistry) | 황대석
  • Uk-Kyu Kim(Department of Oral and Maxillofacial Surgery, School of Dentistry) | 김욱규
  • Hyungwoo Kim(Division of Pharmacology, School of Korean Medicine) | 김형우
  • Mi Heon Ryu(Department of Oral Pathology, BK21 Plus project, School of Dentistry, Pusan National University, Yangsan, South Korea) | 류미현